Table 1 Clinical characteristics of cohort
From: DNA methylation of HOXD3 as a marker of prostate cancer progression
Clinical characteristic | |
|---|---|
Age (years) | |
Average | 61.5 |
Range | 41–75 |
Pathological stage | No. of patients (%) |
pT2 | 144 (62.1) |
pT3a | 57 (24.6) |
pT3b | 25 (10.8) |
pT4 | 6 (2.6) |
Gleason score | |
4 | 3 (1.3) |
5 | 19 (8.2) |
6 | 79 (34.1) |
7 | 107 (46.1) |
8 | 14 (6.0) |
9 | 7 (3.0) |
10 | 3 (1.3) |
Surgical margin status | |
Positive | 59 (25.4) |
Negative | 173 (74.6) |
Total patients | 232 |
